The Role of Continuing Perioperative Chemotherapy Post Surgery in Patients with Esophageal or Gastroesophageal Junction Adenocarcinoma: a Multicenter Cohort Study.

Georgios PapaxoinisKonstantinos KamposiorasJamie M J WeaverZoe KordatouSofia StamatopoulouTheodora GermetakiMagdy NasrallaVikki Owen-HoltAlan AnthoneyWasat Mansoor

Published in: Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract (2019)

Continuation of perioperative chemotherapy post-surgery was not associated with improved outcome in patients with E/GEJ adenocarcinoma. Patients with microscopically residual disease post-surgery might receive a potential benefit from adjuvant chemotherapy.

Keyphrases

minimally invasive
coronary artery bypass
locally advanced
squamous cell carcinoma
surgical site infection
patients undergoing
cardiac surgery
rectal cancer
radiation therapy
clinical trial
percutaneous coronary intervention
cross sectional
acute kidney injury
risk assessment
climate change